Navigation Links
Superior Controls and Banks Integration Group Merge, Creating Industry-Leading Biotech System Integration Company
Date:4/11/2017

Superior Controls, Inc., (“Superior Controls”) a leading control system integrator of custom industrial automation and IT solutions, is pleased to announce it has merged with Banks Integration Group (“Banks Integration”), a leading systems integrator headquartered in Vacaville, CA outside San Francisco. The combination, which is the first investment of its kind for Superior Controls, closed on March 31, 2017. Financial terms were not disclosed.

Banks Integration will retain its name as it becomes a subsidiary of Superior Controls and will continue supporting its clients seamlessly through this transition. Banks Integration’s founder, Greg Banks, will continue his role as President and remains a significant investor in the company.

The transaction combines the talents of two of the most experienced and respected integration companies serving biotechnology and pharmaceutical companies. Customers will have unparalleled access and support of value-added engineering services, nationwide, to configure, implement and maintain highly automated, technically advanced and tightly controlled manufacturing processes under difficult regulated environments.

“We are very excited to be joining forces with the leading West Coast systems integrator for the biotech industry,” said Rick Pierro, Co-Founder and President of Superior Controls. “Greg and I have enjoyed working together for many years dating back to when I was president of the Boston Chapter of the International Society for Pharmaceutical Engineering (ISPE); and he was president of the San Francisco ISPE chapter. This is a wonderful opportunity to formally collaborate to better serve our customers with multiple offices from coast to coast."

As of March 31, 2017, Banks Integration has 36 employees in the Bay Area which will be added to Superior Controls’ 77 employees. With over 100 experienced engineers, the combined company will be among the largest control system integrators in the country. Each of the companies has over two decades of experience in the biotech industry and extensive expertise in other industries, such as food and beverage.

"We are delighted to be combining with Superior Controls. This merger will enable us to better serve our customers throughout the country,” said Greg Banks. “We anticipate a smooth and exciting transition - this is a win-win for both companies, our employees as well as our clients.”

About Superior Controls, Inc.
Since 1993, Superior Controls, Inc. has reliably delivered professionally executed automation and control systems integration services to leading companies in 30 separate states and 15 countries. In addition to being six-time certified by the Control System Integrators Association (CSIA), Superior Controls has passed over fifty management and validation audits performed by industry leaders such as Pfizer, Biogen, GE Healthcare, and more. As Superior Controls now undergoes expansion, it will exhibit the same commitment to innovation and quality that customers have come to expect over the last 24 years. For more information, visit http://www.superiorcontrols.com

About Banks Integration Group
Since being established in 1994, Banks Integration Group has always focused on the customer’s needs, using technology and creative solutions that best fit their operation. Focusing on the Life Science Industry, Banks has developed an excellent reputation for executing GMP projects on the West Coast. In 2010, Banks Integration Group became the only Life Science focused Rockwell Automation Solution Partner in California, and has since doubled in size to meet customer demand. For more information, visit http://www.banksintegration.com

Read the full story at http://www.prweb.com/releases/Superior-Controls/Banks-Integration/prweb14230756.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
2. Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
3. Lillys Investigational GLP-1 Receptor Agonist, Dulaglutide, Showed Superior Glycemic Control Versus Comparators in Patients with Type 2 Diabetes
4. New Study Reveals that PEEK Polymer Spinal Cage Is Superior to Titanium in Surgical Treatment of Multilevel Cervical Spondylotic Myelopathy
5. Salimetrics Cortisol Assay Superior in Comparison Study
6. Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors: Featuring 174 Companies
7. Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
8. Primordial Solutions Testing its Soil Enhancers in California Vineyard to Develop Superior Wine Grape and Enhance Vintner Yield
9. Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
10. Superior Controls Announces Passing 50th Consecutive Biotech Supplier FDA-Required Quality Audit
11. Superior Controls Named Among “Best-of-the-Best” Professional Service Organizations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... 2017 , ... For the second time in three years, ... Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October 10th, ... mission is to change the trajectory of STEM education in America by dramatically ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):